A small, battery-powered thermometer can help monitor temperature levels
These documents suggest monitoring and adjusting HRT dosages for patients experiencing significant weight changes, as these could impact hormone levels and therapy effectiveness
9 July 2026 7 min RF microneedling explained: how radiofrequency boosts collagen results How radiofrequency turns standard microneedling into a deeper collagen treatment, what it realistically fixes, session counts, and the honest safety picture
We do not let you quit three weeks in because no one told you to eat half your usual dinner on injection night
The SURPASS-CVOT trial is a phase 3, randomized, double-blind cardiovascular outcomes trial that will assess tirzepatide for both non-inferiority and superiority against dulaglutide. For dulaglutide, this effect is already proven: According to the Trulicity website, the drug may be used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors. How do I know which medication is right for me
Cell Metabolism, 2019 doi:10.1016/j.cmet.2018.12.008